Andrea Carolan Speers Sells 1,131 Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Stock

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) CAO Andrea Carolan Speers sold 1,131 shares of the firm’s stock in a transaction that occurred on Wednesday, January 12th. The shares were sold at an average price of $15.67, for a total value of $17,722.77. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Andrea Carolan Speers also recently made the following trade(s):

  • On Monday, January 3rd, Andrea Carolan Speers sold 1,330 shares of Tabula Rasa HealthCare stock. The shares were sold at an average price of $15.67, for a total value of $20,841.10.

Shares of Tabula Rasa HealthCare stock opened at $15.02 on Friday. The business’s fifty day moving average price is $13.45 and its two-hundred day moving average price is $27.21. The company has a debt-to-equity ratio of 5.15, a current ratio of 1.35 and a quick ratio of 1.27. The company has a market capitalization of $386.30 million, a P/E ratio of -3.90 and a beta of 1.05. Tabula Rasa HealthCare, Inc. has a 1-year low of $10.05 and a 1-year high of $69.31.

Tabula Rasa HealthCare (NASDAQ:TRHC) last posted its quarterly earnings data on Thursday, November 4th. The company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.19) by $0.15. Tabula Rasa HealthCare had a negative return on equity of 44.56% and a negative net margin of 27.37%. The company had revenue of $86.60 million for the quarter, compared to the consensus estimate of $88.54 million. During the same quarter in the previous year, the business earned ($0.35) EPS. The company’s quarterly revenue was up 22.8% compared to the same quarter last year. On average, research analysts expect that Tabula Rasa HealthCare, Inc. will post -1.75 earnings per share for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Spouting Rock Asset Management LLC raised its stake in shares of Tabula Rasa HealthCare by 7.5% in the 2nd quarter. Spouting Rock Asset Management LLC now owns 4,888 shares of the company’s stock worth $244,000 after buying an additional 340 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of Tabula Rasa HealthCare by 54.2% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,315 shares of the company’s stock worth $66,000 after buying an additional 462 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Tabula Rasa HealthCare by 6.1% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 8,825 shares of the company’s stock worth $441,000 after buying an additional 509 shares in the last quarter. Redmond Asset Management LLC raised its stake in shares of Tabula Rasa HealthCare by 7.5% in the 3rd quarter. Redmond Asset Management LLC now owns 10,605 shares of the company’s stock worth $278,000 after buying an additional 739 shares in the last quarter. Finally, FORA Capital LLC bought a new stake in shares of Tabula Rasa HealthCare in the 2nd quarter worth $40,000. 85.31% of the stock is currently owned by institutional investors.

A number of equities research analysts have weighed in on TRHC shares. Piper Sandler lowered their price objective on Tabula Rasa HealthCare from $41.00 to $13.00 and set a “neutral” rating for the company in a research note on Friday, November 5th. Zacks Investment Research upgraded Tabula Rasa HealthCare from a “sell” rating to a “hold” rating and set a $17.00 target price for the company in a research report on Friday, January 7th. SVB Leerink decreased their target price on Tabula Rasa HealthCare from $40.00 to $23.00 and set a “market perform” rating for the company in a research report on Monday, November 8th. Royal Bank of Canada decreased their target price on Tabula Rasa HealthCare from $70.00 to $23.00 and set an “outperform” rating for the company in a research report on Monday, November 8th. Finally, Benchmark decreased their target price on Tabula Rasa HealthCare from $55.00 to $30.00 and set a “buy” rating for the company in a research report on Tuesday, November 9th. Seven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $27.80.

About Tabula Rasa HealthCare

Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.

Featured Article: What is a Swap?

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.